Roche has announced the opening of its new Pharma Research and Early Development (pRED) Centre at its global headquarters in Basel, Switzerland. Equipped with cutting-edge technologies and housing around 1,000 state-of-the-art laboratory and office workplaces, the new center brings together teams of scientists and researchers to accelerate scientific discoveries for patients.
The new pRED Center consists of two high-rise laboratory buildings (114m, 72m), with cutting-edge lab technologies and digital solutions, alongside an office building and a convention centre (26m, 18m). In total, there are 33 combined laboratories and office floors with 150 labs and workplaces for around 1,800 researchers. The state-of-the-art buildings have been deliberately designed to foster collaboration and an end-to-end mindset, aiming to deliver the most transformative medicines to patients faster.
Thomas Schinecker, CEO of the Roche Group, said: “The new pRED Center will play an integral role in collaborating with our research centers across the globe, aiming to boost the effectiveness and efficiency of our R&D, and to deliver the greatest impact for patients.”